| Download ( PDF | 1MB) |
Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells
Article
Voloshanenko, Oksana, Erdmann, Gerrit
, Dubash, Taronish D., Augustin, Iris, Metzig, Marie, Moffa, Giusi, Hundsrucker, Christian, Kerr, Grainne, Sandmann, Thomas
, Anchang, Benedikt, Demir, Kubilay, Boehm, Christina, Leible, Svenja, Ball, Claudia R.
, Glimm, Hanno, Spang, Rainer and Boutros, Michael
(2013)
Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells.
Nature communications 4, p. 2610.
DOI to cite this document: 10.5283/epub.30529
Abstract
Aberrant regulation of the Wnt/beta-catenin pathway has an important role during the onset and progression of colorectal cancer, with over 90% of cases of sporadic colon cancer featuring mutations in APC or beta-catenin. However, it has remained a point of controversy whether these mutations are sufficient to activate the pathway or require additional upstream signals. Here we show that ...
Aberrant regulation of the Wnt/beta-catenin pathway has an important role during the onset and progression of colorectal cancer, with over 90% of cases of sporadic colon cancer featuring mutations in APC or beta-catenin. However, it has remained a point of controversy whether these mutations are sufficient to activate the pathway or require additional upstream signals. Here we show that colorectal tumours express elevated levels of Wnt3 and Evi/Wls/GPR177. We found that in colon cancer cells, even in the presence of mutations in APC or beta-catenin, downstream signalling remains responsive to Wnt ligands and receptor proximal signalling. Furthermore, we demonstrate that truncated APC proteins bind beta-catenin and key components of the destruction complex. These results indicate that cells with mutations in APC or beta-catenin depend on Wnt ligands and their secretion for a sufficient level of beta-catenin signalling, which potentially opens new avenues for therapeutic interventions by targeting Wnt secretion via Evi/Wls.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||||||||||||||||||||||||||||||||||||||
| Journal or Publication Title | Nature communications | ||||||||||||||||||||||||||||||||||||||||
| Publisher | NATURE PUBLISHING GROUP | ||||||||||||||||||||||||||||||||||||||||
| Place of Publication | LONDON | ||||||||||||||||||||||||||||||||||||||||
| Volume | 4 | ||||||||||||||||||||||||||||||||||||||||
| Page Range | p. 2610 | ||||||||||||||||||||||||||||||||||||||||
| Date | 28 October 2013 | ||||||||||||||||||||||||||||||||||||||||
| Date of publication | 05 Aug 2014 09:29 | ||||||||||||||||||||||||||||||||||||||||
| Institutions | Medicine > Institut für Funktionelle Genomik > Lehrstuhl für Statistische Bioinformatik (Prof. Spang) Informatics and Data Science > Department Computational Life Science > Lehrstuhl für Statistische Bioinformatik (Prof. Spang) | ||||||||||||||||||||||||||||||||||||||||
| Identification Number |
| ||||||||||||||||||||||||||||||||||||||||
| Classification |
| ||||||||||||||||||||||||||||||||||||||||
| Keywords | PHOSPHORYLATED BETA-CATENIN; COLORECTAL-CANCER; STEM-CELLS; WNT/BETA-CATENIN; ADENOMATOUS POLYPOSIS; SOMATIC MUTATIONS; SIGNAL-TRANSDUCTION; TRUNCATED APC; IN-VIVO; PROTEIN; | ||||||||||||||||||||||||||||||||||||||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine 500 Science > 570 Life sciences 600 Technology > 610 Medical sciences Medicine | ||||||||||||||||||||||||||||||||||||||||
| Status | Published | ||||||||||||||||||||||||||||||||||||||||
| Refereed | Yes, this version has been refereed | ||||||||||||||||||||||||||||||||||||||||
| Created at the University of Regensburg | Partially | ||||||||||||||||||||||||||||||||||||||||
| URN of the UB Regensburg | urn:nbn:de:bvb:355-epub-305292 | ||||||||||||||||||||||||||||||||||||||||
| Item ID | 30529 |
Download Statistics
Download Statistics